ArticleOncotarget2017

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.

Joo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.